Membio is on a mission to ensure the world has a safe and sufficient supply of blood. Globally, only 40% of the world's need for blood is able to be supplied from the current donation system, leaving over $60+ Billion in unfulfilled market demand. Even in the USA, there is a perpetual shortage for universally accepted O negative blood. At Membio we are developing a viable and scalable alternative to the donation system. By cost-effective manufacturing red blood cells outside the body, we are able to produce an unlimited amount of transfusion quality RBCs while eliminating donor recruitment and blood collection, testing, and processing. Our fully functional better than O negative RBCs increase patient safety by having reduced immunogenicity and being pathogen and toxin-free. These superior quality RBCs from specialized cell lines and are grown in our novel manufacturing system. This manufacturing system combines scalability with microenvironment to achieve cost-effective production on an industrial scale."
Something looks off?